Lupus patients may get a boost from doctors checking their prescription refill records
NCT ID NCT03738826
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study tests a simple idea: giving lupus doctors a quick look at their patients' pharmacy refill history during a clinic visit. The goal is to help doctors spot when someone is struggling to take their lupus medications and talk about ways to overcome those barriers. The study includes follow-up patients at a lupus clinic and focuses on whether this approach is practical and helpful.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a behavioral intervention where lupus clinic providers are prompted to review pharmacy refill data and discuss adherence barriers during the patient visit
- What this could lead to
- If successful, this approach could help people with lupus take their medications more consistently, potentially leading to better disease control and fewer flare-ups.
- What could go wrong
- This is a small pilot study focused on feasibility, so it may not prove that the intervention actually improves adherence or health outcomes. Results may not apply to other clinics or patient populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University
Durham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app bridge the lupus care gap for women of color?
- Blood traps may reveal lupus kidney treatment success
- Can a peer coach help young people take control of their chronic illness?
- Engineered immune cells take aim at Hard-to-Treat autoimmune diseases
- New Four-Pronged antibody takes aim at lupus
- Continued anifrolumab treatment studied for lupus and related diseases